Harrow, Inc. (HROW)
35.01
+1.01
(+2.97%)
USD |
NASDAQ |
Mar 24, 13:33
Harrow Total Assets (Quarterly) : 405.21M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 838.03M |
| Esperion Therapeutics, Inc. | 883.74M |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Theravance Biopharma, Inc. | 485.57M |
| Rhythm Pharmaceuticals, Inc. | 481.19M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 353.12M |
| Shareholders Equity (Quarterly) | 52.45M |
| Debt to Equity Ratio | 4.804 |
| Current Ratio | 2.199 |
| Net Debt Paydown Yield | -0.61% |